Breaking Finance News

West Pharmaceutical (NYSE:WST) has been upgraded from Hold to Buy in a statement by Jefferies & Co earlier today.

Jefferies & Co has upgraded West Pharmaceutical (NYSE:WST) from Hold to Buy in a statement released on 9/15/2017.

Having a price of $96.12, West Pharmaceutical (NYSE:WST) traded 3.85% higher on the day. With the last stock price up 6.73% from the two hundred day average, compared with the Standard & Poor's 500 Index which has increased 0.04% over the same period. WST has recorded a 50-day average of $87.31 and a two hundred day average of $89.20. Trade Volume was down over the average, with 161,764 shares of WST changing hands under the typical 367,208

Recent Performance Chart

West Pharmaceutical (NYSE:WST)

West Pharmaceutical has PE ratio of 40.86 with a one year low of $70.17 and a one year high of $99.91 and has a market capitalization of $0.

A total of 4 brokerages have issued a ratings update on West Pharmaceutical. Two brokerages rating the company a strong buy, one equity analyst rating the company a buy, one equity analyst rating the company a hold, zero equity analysts rating the company a underperform, and finally zero equity analysts rating the company a sell with a one year target of $66.00.

Brief Synopsis About West Pharmaceutical (NYSE:WST)

West Pharmaceutical Services, Inc. is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Company's products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services. The Company's segments include Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment develops commercial and operational strategies across its global network, with specific emphasis on product offerings to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as an integrated business focused on the design, manufacture and automated assembly of various devices, primarily for pharmaceutical, diagnostic and medical device customers.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.